Paper41326795
RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer.
Treekitkarnmongkol W and 19 others. Nat Cell Biol, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. RASH3D19 mediates RAS activation through a positive feedback loop in KRAS-mutant cancer. Papers, record 41326795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41326795
- Cell line
- PANC-1348 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records8
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines8
- PANC-1The paper gives its RRID348 papers
- MIA PaCa-2The paper gives its RRID295 papers
- AsPC-1The paper gives its RRID220 papers
- BxPC-3The paper gives its RRID216 papers
- HPAF-IIThe paper gives its RRID83 papers
- SW837The paper gives its RRID62 papers
- NCI-H1792The paper gives its RRID51 papers
- HPDEThe paper gives its RRID15 papers
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Proto-Oncogene Proteins p21(ras) | Major topic |
| Mutation | Major topic |
| Pancreatic Neoplasms | Major topic |
| Carcinoma, Pancreatic Ductal | Major topic |
| Colorectal Neoplasms | Major topic |
| Humans | |
| Animals | |
| Signal Transduction | |
| MicroRNAs | |
| Cell Line, Tumor | |
| Feedback, Physiological | |
| Mice | |
| Gene Expression Regulation, Neoplastic | |
| Xenograft Model Antitumor Assays | |
| ErbB Receptors | |
| Mice, Nude | |
| Cell Proliferation |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA016672 | NCI NIH HHS | United States | P30CA016672 | PubMed | NIH RePORTER |
| U01 CA214263 | NCI NIH HHS | United States | U01CA214263 | PubMed | NIH RePORTER |
| U01 CA252965 | NCI NIH HHS | United States | U01CA252965 | PubMed | NIH RePORTER |
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21245048 | NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21245048 | PubMed |
| 2 | 39529638 | Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples. | Gastro Hep Adv | 2024 | https://conductscience.org/library/papers/39529638 | PubMed |
| 3 | 34096690 | Sotorasib for Lung Cancers with KRAS p.G12C Mutation. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34096690 | PubMed |
| 4 | 25323927 | Drugging the undruggable RAS: Mission possible? | Nat Rev Drug Discov | 2014 | https://conductscience.org/library/papers/25323927 | PubMed |
| 5 | 31062644 | Anchorage-independent growth conditions reveal a differential SOS2 dependence for transformation and survival in RAS-mutant cancer cells. | Small GTPases | 2021 | https://conductscience.org/library/papers/31062644 | PubMed |
| 6 | 30918400 | Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. | Nature | 2019 | https://conductscience.org/library/papers/30918400 | PubMed |
| 7 | 36546651 | Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer. | N Engl J Med | 2023 | https://conductscience.org/library/papers/36546651 | PubMed |
| 8 | 21113131 | miR-301a as an NF-κB activator in pancreatic cancer cells. | EMBO J | 2011 | https://conductscience.org/library/papers/21113131 | PubMed |
| 9 | 24256730 | K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. | Nature | 2013 | https://conductscience.org/library/papers/24256730 | PubMed |
| 10 | 14551139 | Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein. | Blood | 2004 | https://conductscience.org/library/papers/14551139 | PubMed |
| 11 | 37277530 | An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance. | Nat Cancer | 2023 | https://conductscience.org/library/papers/37277530 | PubMed |
| 12 | 38637634 | Targeting KRAS in cancer. | Nat Med | 2024 | https://conductscience.org/library/papers/38637634 | PubMed |
| 13 | 31457089 | Cell cycle progression in confining microenvironments is regulated by a growth-responsive TRPV4-PI3K/Akt-p27Kip1 signaling axis. | Sci Adv | 2019 | https://conductscience.org/library/papers/31457089 | PubMed |
| 14 | 30181243 | Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation. | Sci Signal | 2018 | https://conductscience.org/library/papers/30181243 | PubMed |
| 15 | 34919824 | Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial. | Lancet Oncol | 2022 | https://conductscience.org/library/papers/34919824 | PubMed |
| 16 | 37068173 | Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC. | Cancer Discov | 2023 | https://conductscience.org/library/papers/37068173 | PubMed |
| 17 | 21873159 | Oncogenic KRAS regulates miR-200c and miR-221/222 in a 3D-specific manner in colorectal cancer cells. | Anticancer Res | 2011 | https://conductscience.org/library/papers/21873159 | PubMed |
| 18 | 22340593 | Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73. | Cancer Cell | 2012 | https://conductscience.org/library/papers/22340593 | PubMed |
| 19 | 20093556 | MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions. | Clin Chem | 2010 | https://conductscience.org/library/papers/20093556 | PubMed |
| 20 | 15766527 | RAS is regulated by the let-7 microRNA family. | Cell | 2005 | https://conductscience.org/library/papers/15766527 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42131811 | Downregulation of microRNA-300-3p promotes steatosis-to-MASH progression by regulating STX17. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42131811 |
Source PubMed
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| ETS1 | 2113 | PubTator's text mining | https://conductscience.org/library/genes/2113 | NCBI Gene |
| GAB1 | 2549 | PubTator's text mining | https://conductscience.org/library/genes/2549 | NCBI Gene |
| GRB2 | 2885 | PubTator's text mining | https://conductscience.org/library/genes/2885 | NCBI Gene |
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 | NCBI Gene |
| MIR222 | 407007 | PubTator's text mining | https://conductscience.org/library/genes/407007 | NCBI Gene |
| MIR301A | 407027 | PubTator's text mining | https://conductscience.org/library/genes/407027 | NCBI Gene |
| PTPN11 | 5781 | PubTator's text mining | https://conductscience.org/library/genes/5781 | NCBI Gene |
| SOS2 | 6655 | PubTator's text mining | https://conductscience.org/library/genes/6655 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41326795
GET https://conductscience.org/api/papers/v1/41326795/references?page=2